Watching this system has become like cheering for an elephant on a unicycle

This logic has manifested in the newly released guidance to companies interested in pursuing a broad listing for cancer immunotherapies. An expectation of no net cost. Patients, you waited nine years for this, and it was granted on the basis that your treatment cost the government nothing. That is what your life is worth. …